The Epigenetic Theory of Carcinogenesis: p53 as the Guardian of The Epigenome
Journal Title: Journal of Oncology and Cancer Research - Year 2017, Vol 1, Issue 1
Abstract
The principal advantage of the hypothesis that the multiple phenotypic abnormalities characteristic of malignant and pre-malignant cells result from epigenetic disorder is that it accounts for the wide spectrum of anomalies exhibited by these cells without recourse to postulating a raised mutation rate. The basic proposal is that derangement of the process of copying the epigenetic pattern during proliferation of differentiated stem cells enables dysregulated genetic re-programming and de-differentiation of the affected progeny, a phenomenon that might be termed “epimutation”. This results in the generation of abnormal clones expressing divergent structural and functional characteristics, some of which embue the cells with malignant properties. The epigenetic theory of carcinogenesis postulates that the initiating mutations cause deranged vertical transmission of the epigenetic pattern established in proliferating differentiated stem cells. The failure of fidelity of copying the epigenetic pattern results in changes of expression of genes, including the re-expression of previously silenced genes characteristic of earlier developmental stages or of other tissues. The mechanism involves the generation of chromosomal abnormalities and deranged cellular organization. Some clones acquire properties that render them capable of transgressing tissue boundaries and proliferating in distant sites, i.e. they exhibit malignant behavior. The mathematical features of the theory are concomitant with established accounts of age-specific incidence of adult human malignancies and the proposed mechanism accounts for the known characteristics of cancer.
Authors and Affiliations
Patrick A Riley
Keywords
Related Articles
- EP ID EP249309
- DOI 10.28967/jocr.2017.01.17002
- Views 123
- Downloads 0
Have Cluster Randomised Trials a Role in Health Care Research?
Cluster Randomised trials, where groups of individuals are randomised to different treatments and outcomes measured on individuals, have many limitations inherent in the trial design. Selection bias can be introduced int...
Appropriate Selection of Segmentectomy for Patients with Early Stage Non-small Cell Lung Cancer
Several randomized-control trials of lung cancer screening, including USA National Lung Cancer Screening Trial (NLST) and Dutch-Belgian Randomized Lung Cancer Screening Trial (NELSON), have explored the value of low-dose...
Evaluation of Phosphorylated Proteins Involved in the Epidermal Growth Factor Receptor (EGFR) Signaling Pathway to Predict the Response of Patients with Breast Cancer to Neoadjuvant Chemotherapy Regimens with Weekly Paclitaxel: Preliminary Analysis
This preliminary analysis aimed at evaluating the capacity of epidermal growth factor receptor (EGFR) signaling pathway phosphorylated proteins as predictors of the pathologic response of breast cancer patients treated w...
Objectively Recorded Physical Activity And Perceived Distress At The Beginning Of Oncological Treatment
Purpose: To examine the association between physical activity (PA), objectively recorded as number of steps and hours of moderate- to- vigorous intensity PA, and self- reported distress (anxiety, depression, intrusion an...
Management of Biochemical Failure of Prostate Cancer after Radical prostatectomy: Recent Advances and Future Opportunities
Prostate cancer is the most common new cancer diagnosis and the third leading cause of cancer death in men in the United States. With the use of prostate-specific antigen (PSA) as a screening test, most new prostate canc...